Pharvaris
Price & Volume
Stats
See more52W Range | $12.01-$29.85 |
Market Cap | $1.7B |
Shares Short | 712,119 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.46 |
News
See moreYahoo Finance • 4 days ago
Texas Instruments upgraded, Circle downgraded: Wall Street's top analyst calls
Yahoo Finance • 25 days ago
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit
Yahoo Finance • last month
Validation of Patient-Reported Outcomes in the On-Demand Treatment of Hereditary Angioedema Attacks Published in Clinical Reviews in Allergy & Immunology
Yahoo Finance • 4 months ago
What Does Wall Street Think About Pharvaris N.V. (PHVS)?
About
CEO | Mr. Berndt Axel Edvard Modig CPA, M.B.A. |
CFO | Mr. David W. Nassif J.D. |
Address | Grafenauweg 8, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 129 |
